logo
15:59 Feb 25

Aarti Pharmalabs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
708.30
+17.40 (+2.52%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Aarti Pharmalabs Ltd. Financials

Aarti Pharmalabs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
708.30
+17.40 (+2.52%)
15:59 Feb 25
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

33/100
Technically Bearish

Strength

5

Weakness

7

Opportunity

1

Threats

0

13.68 %

ROE %

9.37 %

ROA %

23.57

EPS

219.55

BVPS

12.87 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1199.94 1945.23 1852.61 2115.07
Operating Expenses +
993 1603.19 1466.56 1650.7
Raw Material
774.16 1295.12 1040.67 1063.65
Increase Decrease in Cost
-49.05 -125.36 -19.95 64.22
Other Manufacturing Expense
154.59 235.71 0 0
Employee Cost
85.2 129.69 138.41 161.96
Miscellaneous Expenses
353.94 629.67 671.87 714.13
Operating Profit
206.94 342.04 386.05 464.37
Other Income
2.51 2.32 4.9 10.12
Depreciation
42.12 62.54 73.24 86.9
Interest
11.96 21.05 17.21 26.9
Profit before tax and exceptio..
155.38 260.77 300.49 360.69
Exceptional Items
0 0 0 0
PBT
155.38 260.77 300.49 360.69
Provision for Taxation
33.13 67.28 83.59 88.28
Net Profit
122.25 193.49 216.9 272.4
NET Profit after MI
122.25 193.49 216.9 272.4
EPS
13.49 21.35 23.93 30.04
Operating Profit Margin (%)
17.25 17.58 20.84 21.96
Net Profit Margin (%)
10.19 9.95 11.71 12.88

Aarti Pharmalabs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 43.10 42.90 43.70 44.30 44.70 46.10
FII 7.70 8.00 7.30 7.40 8.60 7.40
Public 7.70 7.00 7.90 7.50 10.40 11.30
Others 41.50 42.10 41.10 40.80 36.30 35.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: